UHD joins forces with leading cancer care company to bring £50m boost to NHS patients

University Hospitals Dorset (UHD) is partnering with GenesisCare UK to provide private cancer services to patients across Dorset, bringing more than £50m in investment into NHS cancer care over the next 20 years.

GenesisCare will develop a state-of-the-art private patient facility delivering radiotherapy and Systemic Anti-Cancer Therapy (SACT) services at Poole Hospital. This will include chemotherapy and immunotherapy and will be for patients with medical insurance or those wishing to self-pay. This additional investment, alongside UHD’s existing funding, will increase capacity, help patients begin treatment sooner, and fund the recruitment of additional consultants to support NHS care.

As a result of UHD’s transformation programme, space became available at Poole Hospital and local cancer doctors spotted an opportunity to use this to help improve patient services, while creating a new income stream for the Trust.

Dr Ben Masters, lead oncologist at UHD, said “The deal is really beneficial to our NHS as the income generated can be reinvested in NHS care. We can also use GenesisCare’s expertise to benefit patients here in Dorset.

“GenesisCare’s bid stood out because of their focus on exemplary patient care, the latest innovations in evidence-based treatments, research and committing to long-term resources that enables the recruitment of more NHS staff.”

Paul Gearing, Chief Growth Officer from GenesisCare, said: “We are thrilled that University Hospital Dorset selected GenesisCare as its partner of choice, and we’re proud to bring UHD into the GenesisCare family.  By combining local clinical excellence with the benefit of GenesisCare's national network of expertise we will create something very special that will deliver tangible benefits to both the NHS and to patients wanting to access private cancer care. 

“This is an exciting milestone for GenesisCare and a significant investment into the future of cancer care in Dorset. We have long believed there is a strong demand for greater access to private cancer services in the region, and this partnership creates a unique opportunity to meet that need with a purpose built, dedicated private patient unit, located alongside the NHS, delivering the latest radiotherapy and systemic anti-cancer therapies.”

GenesisCare and UHD are finalising the designs for this state-of-the-art facility with a view to offering this dedicated private cancer service closer to home from Autumn 2027.

About GenesisCare

GenesisCare UK is the UK’s leading cancer care provider, specialising in the treatment of complex cancers and transforming cancer care with advanced diagnostics, medical oncology, radiotherapy and Theranostics. Operating 14 specialist outpatient centres, with additional centres opening in Leeds and Royal Tunbridge Wells in 2026, we provide patients with world-class care from the UK's top clinical and healthcare teams, and deliver the most advanced, safe and effective cancer care treatments. With a philosophy of treating the whole patient not just their cancer, we take an integrated approach to cancer care, including Exercise Medicine which is proven to improve patient’s tolerance for treatment and aids their long-term recovery. We also work with universities and leading clinicians around the world, to research and design new and better ways to treat cancers and have a growing UK clinical trials programme to support bringing new therapies to more patients. Treatments are available for patients with health insurance and those paying for their own care.